Company / Operating Income
Arcutis Biotherapeutics, Inc. Operating Income History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$12.2M
FY2025
5-year range
-$301.6M / -$12.2M
FY2021-FY2025
Trend
+90.5%
vs FY2024
Sector context
#60 of 204
Health Care
What the data says
At -$12M, Arcutis Biotherapeutics, Inc.'s operating income ranks #60 of 204 in the Health Care sector. Operating Income has increased for 3 consecutive years, from -$302M in FY2022 to -$12M in FY2025.
Based on SEC 10-K filings.
-$12M in FY2025.
Improved from -$241M to -$12M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#60 of 204 in Health CareTop 29% of 204This company -$12.2M Sector average $107.8M
▼
-111.3% below sector average
Key checks
Key Insights
- Arcutis Biotherapeutics, Inc.'s operating income has grown for 3 consecutive years.
- In FY2025, operating income increased 90.5% year-over-year.
- Ranks #60 out of 204 companies in the Health Care sector.
- Lowest operating income in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -0.65 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$12.2M | +90.5% |
| FY2024 | -$128.4M | +46.7% |
| FY2023 | -$241.1M | +20.1% |
| FY2022 | -$301.6M | -46.0% |
| FY2021 | -$206.5M | -51.1% |
| FY2020 | -$136.6M | -216.8% |
| FY2019 | -$43.1M | -118.6% |
| FY2018 | -$19.7M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026